Publication dates

Growth Hormone Industry, October 2014 Market Reports from Top Publishers

You might be interested in: Protein, Drug Delivery, Biosimilar, more »


 
1-10 of 35 reports for Growth Hormone

Bio Products Markets in China

Bio Products Markets in China

  • $ 4 000
  • Industry report
  • November 2014
  • by Asia Market Information & Development Company

... growth hormones production, demand and foreign traderecombinant human growth hormones output and demandrecombinant human growth hormones major producer and their market share ...

Biomm S.A. (Symbol:BIOM4) SWOT Analysis, Strategy, Revenues and Profits

Biomm S.A. (Symbol:BIOM4) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Insulin and other recombinant proteins. Its technology is used in the production of therapeutic proteins, such as calcitonin, interferons and growth hormones. The company offers processes for the production ...

SciGen Limited (Symbol:SIE) SWOT Analysis, Strategy, Revenues and Profits

SciGen Limited (Symbol:SIE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Recombinant human health care biotechnology derived products. Its products include recombinant human growth hormone, second generation recombinant human insulin, and recombinant human granulocyte ...

Growth Hormone Deficiency - Pipeline Review, H2 2014

Growth Hormone Deficiency - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • August 2014
  • by Global Markets Direct

... Stages of development ranging from pre-registration till discovery and undisclosed stages- a detailed assessment of monotherapy and combination therapy pipeline projects- coverage of the growth ...

Global Markets for Bioengineered Protein Drugs

Global Markets for Bioengineered Protein Drugs

  • $ 6 650
  • Industry report
  • August 2014
  • by BCC Research

... And fertility disorders, by region, through2019 ($ millions)132table 45 market share for bioengineered protein drugs by application ingrowth hormone, enzyme and fertility disorders, by region ...

 Growth Hormone Deficiency-Pipeline Insights, 2014

Growth Hormone Deficiency-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under growth hormone deficiency. This report provides information ...

Phage Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Phage Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... On protein products division manufactures and sells recombinant protein pharmaceuticals. Its nasal delivery of protein products consist of nasal growth hormone, nasal beta interferon, nasal g-csf and nasal pth ...

Asterion Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Asterion Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Of chronic and acute disorders. Its products include growth hormone agonists, erythropoietin, and granulocyte colony stimulating factor. Asterion uses profuse technology platform to engineer proteins for human ...

Versartis, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Versartis, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Is exclusively designed to reduce the burden of daily injection therapy which is used in the treatment of growth hormone deficiency in both children and adults. Versartis utilizes half ...

 Growth Hormone Deficiency Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Growth Hormone Deficiency Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Evaluate the marketing status and exclusivity details of growth hormone deficiency key products to exploit opportunities for generic drug development opportunities. - Identify and understand important ...

About 600 reports for Growth Hormone

Download Unlimited Documents from Trusted Public Sources

Novo Nordisk Annual Report 2013

  • Business Strategy
  • January 2013
    116 pages
  • Diabete  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.